China Chemical & Pharmaceutical Co., Ltd.

TWSE:1701 Stock Report

Market Cap: NT$6.7b

China Chemical & Pharmaceutical Past Earnings Performance

Past criteria checks 1/6

China Chemical & Pharmaceutical's earnings have been declining at an average annual rate of -1%, while the Pharmaceuticals industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 2.4% per year. China Chemical & Pharmaceutical's return on equity is 4.4%, and it has net margins of 3.7%.

Key information

-1.0%

Earnings growth rate

-1.0%

EPS growth rate

Pharmaceuticals Industry Growth18.5%
Revenue growth rate2.4%
Return on equity4.4%
Net Margin3.7%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Here's Why We Think China Chemical & Pharmaceutical (TPE:1701) Is Well Worth Watching

Apr 25
Here's Why We Think China Chemical & Pharmaceutical (TPE:1701) Is Well Worth Watching

We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt

Apr 07
We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt

The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 34% And Shareholders Are Holding On

Mar 17
The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 34% And Shareholders Are Holding On

China Chemical & Pharmaceutical Co., Ltd.'s (TPE:1701) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Feb 24
China Chemical & Pharmaceutical Co., Ltd.'s (TPE:1701) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Is China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) A Good Fit For Your Dividend Portfolio?

Jan 27
Is China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) A Good Fit For Your Dividend Portfolio?

Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?

Jan 06
Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?

The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 22% And Shareholders Are Holding On

Dec 16
The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 22% And Shareholders Are Holding On

China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Nov 26
China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Revenue & Expenses Breakdown

How China Chemical & Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TWSE:1701 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 248,7623282,440472
31 Dec 238,5753222,416486
30 Sep 238,6193172,513463
30 Jun 238,5993872,474470
31 Mar 238,5724892,348457
31 Dec 228,4574782,283436
30 Sep 228,1475262,076417
30 Jun 227,9815282,016400
31 Mar 227,9364772,070399
31 Dec 217,9495182,062391
30 Sep 218,1024592,222402
30 Jun 218,2114482,216429
31 Mar 218,0885742,124436
31 Dec 208,1815572,134444
30 Sep 208,0615312,040476
30 Jun 208,0065122,057448
31 Mar 208,0754122,121456
31 Dec 197,9703852,150452
30 Sep 197,6303602,143426
30 Jun 197,6693682,161438
31 Mar 197,5473432,135422
31 Dec 187,5803702,125403
30 Sep 187,5623742,042381
30 Jun 187,0833721,787364
31 Mar 186,7143261,571347
31 Dec 176,2453111,301344
30 Sep 175,9882931,160340
30 Jun 175,8482571,130330
31 Mar 175,8223051,103324
31 Dec 165,7813131,077325
30 Sep 165,7853111,050319
30 Jun 165,7713621,046323
31 Mar 165,7173521,032320
31 Dec 155,6283541,040327
30 Sep 155,5684501,043346
30 Jun 155,4713951,017348
31 Mar 155,3503841,009358
31 Dec 145,297348982362
30 Sep 145,257253974363
30 Jun 145,274260976364
31 Mar 145,271266983358
31 Dec 135,174240977355
30 Sep 135,1252561,014338

Quality Earnings: 1701 has high quality earnings.

Growing Profit Margin: 1701's current net profit margins (3.7%) are lower than last year (5.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 1701's earnings have declined by 1% per year over the past 5 years.

Accelerating Growth: 1701's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 1701 had negative earnings growth (-33%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (2.8%).


Return on Equity

High ROE: 1701's Return on Equity (4.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.